Your browser doesn't support javascript.
loading
Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems.
Chang, Jo-Fan; Hsu, Jui-Ling; Sheng, Yi-Hua; Leu, Wohn-Jenn; Yu, Chia-Chun; Chan, She-Hung; Chan, Mei-Ling; Hsu, Lih-Ching; Liu, Shih-Ping; Guh, Jih-Hwa.
Afiliação
  • Chang JF; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Hsu JL; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Sheng YH; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Leu WJ; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Yu CC; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Chan SH; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Chan ML; Department of Cosmetic Science, Providence University, Taichung, Taiwan.
  • Hsu LC; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Liu SP; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Guh JH; Department of Urology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
Front Oncol ; 8: 681, 2018.
Article em En | MEDLINE | ID: mdl-30705876
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article